Cambridge Financial Group, LLC Zoetis Inc. Transaction History

Cambridge Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 09, 2025	SELL	$162.24 - $194.42 $168,567 - $202,002	-1,039 Closed	0 $0
Q3 2024 Sep 09, 2025	BUY	$172.58 - $196.48 $179,310 - $204,142	1,039 New	1,039 $203 Million
Q1 2024 Sep 09, 2025	SELL	$165.67 - $199.94 $171,468 - $206,937	-1,035 Closed	0 $0
Q4 2023 Sep 09, 2025	BUY	$151.44 - $200.09 $156,740 - $207,093	1,035 New	1,035 $204 Million

2,074

423M

1.82M

1.94M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cambridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cambridge Financial Group, LLC with notifications on news.